GRISLIN

Serial Number 76523744
606

Registration Progress

Application Filed
Jun 11, 2003
Under Examination
Apr 6, 2004
Approved for Publication
Dec 24, 2003
Published for Opposition
Jan 13, 2004
Registered

Trademark Image

GRISLIN

Basic Information

Serial Number
76523744
Filing Date
June 11, 2003
Published for Opposition
January 13, 2004
Abandonment Date
October 7, 2005
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 7, 2005
Classes
005

Rights Holder

Maitake Products, Inc.

03
Address
222 Bergen Turnpike
Ridgefield, NJ 07660

Ownership History

Maitake Products, Inc.

Original Applicant
03
Ridgefield, NJ

Maitake Products, Inc.

Owner at Publication
03
Ridgefield, NJ

Legal Representation

Attorney
Rosalie A. Melisz

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

13 events
Date Code Type Description Documents
Dec 5, 2005 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 5, 2005 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Apr 4, 2005 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 4, 2005 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 4, 2005 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 4, 2004 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 23, 2004 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 23, 2004 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 6, 2004 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 13, 2004 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 24, 2003 NPUB O NOTICE OF PUBLICATION Loading...
Nov 5, 2003 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 31, 2003 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
pharmaceutical preparation made from mushrooms for the treatment of hypertension, obesity, diabetes, hyperlipidemia, chronic fatigue syndrome, syndrome X or metabolic syndrome, hepatitis, cancer and HIV positive/AIDS in the forms of tablets, capsules, suppositories and ampule for injection use; and dietary, nutritional and food supplements made from mushrooms in the forms of tablets, capsules, tincture, extract, powder and tea
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005